Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BREAKOUT -International Breast Cancer Biomarker, Standard of Care and Real World Outcomes Study

NCT03078036 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03078036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03078036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BREAKOUT -International Breast Cancer Biomarker, Standard of Care and Real World Outcomes Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
March 13, 2017
Completion date
May 20, 2019
Enrollment
873 (actual)
Sites
98

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer